These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4980360)

  • 21. Recommended criteria for the identification of trachoma and inclusion conjunctivitis agents.
    Schachter J
    J Infect Dis; 1970; 122(1):105-7. PubMed ID: 4914940
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemagglutination by the TRIC group of Chlamydia.
    Elvin-Lewis PF; Czekalowski JW
    J Med Microbiol; 1971 Feb; 4(1):31-41. PubMed ID: 5548601
    [No Abstract]   [Full Text] [Related]  

  • 23. EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT.
    Mitsui Y; Konishi K; Nishimura A; Kajima M; Tamura O; Endo K
    Br J Ophthalmol; 1962 Nov; 46(11):651-9. PubMed ID: 18170828
    [No Abstract]   [Full Text] [Related]  

  • 24. Chlamydial infection. Results of tests for Chlamydia in patients suffering from acute Reiter's disease compared with results of tests of the genital tract and rectum in patients with ocular infection due to TRIC agent.
    Vaughan-Jackson JD; Dunlop EM; Darougar S; Dwyer RS; Jones BR
    Br J Vener Dis; 1972 Dec; 48(6):445-51. PubMed ID: 4651179
    [No Abstract]   [Full Text] [Related]  

  • 25. TRIC agent infections of the eye and genital tract.
    Dawson CR; Schachter J
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1288-98. PubMed ID: 4164870
    [No Abstract]   [Full Text] [Related]  

  • 26. Trachoma vaccine field trials in The Gambia.
    Sowa S; Sowa J; Collier LH; Blyth WA
    J Hyg (Lond); 1969 Dec; 67(4):699-717. PubMed ID: 5261212
    [No Abstract]   [Full Text] [Related]  

  • 27. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys.
    Wang SP; Grayston JT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1133-45. PubMed ID: 4960878
    [No Abstract]   [Full Text] [Related]  

  • 28. Infection of the eye, genitalia, and rectum by a new serotype (type G) of TRIC agent. Clinical and laboratory aspects.
    Dunlop EM; Hare MJ; Darougar S; Dwyer RS
    Br J Vener Dis; 1973 Jun; 49(3):301-5. PubMed ID: 4578215
    [No Abstract]   [Full Text] [Related]  

  • 29. Inclusion bodies in relation to TRIC agent infection.
    Hegab S
    Bull Ophthalmol Soc Egypt; 1971; 64(68):35-42. PubMed ID: 5154731
    [No Abstract]   [Full Text] [Related]  

  • 30. Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum.
    Darougar S; Jones BR; Kinnison JR; Vaughan-Jackson JD; Dunlop EM
    Br J Vener Dis; 1972 Dec; 48(6):416-20. PubMed ID: 4651177
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on oculogenital TRIC agents isolated in Denmark.
    Mordhorst CH
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1282-8. PubMed ID: 6025166
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy.
    Lawn AM; Blyth WA; Taverne J
    J Hyg (Lond); 1973 Sep; 71(3):515-28. PubMed ID: 4518351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of pregnant monkeys and their offspring with TRIC agents.
    Alexander ER; Chiang WT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1145-53. PubMed ID: 4960879
    [No Abstract]   [Full Text] [Related]  

  • 34. Virulence and host specificity of TRIC agents.
    Moore JE; Griffiths MS; Pearce JH
    J Gen Microbiol; 1969 Dec; 59(3):iv-v. PubMed ID: 4984857
    [No Abstract]   [Full Text] [Related]  

  • 35. Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. 4. Laboratory aspects.
    Harper IA; al-Hussaini MK; Dunlop EM; Emarah MH; Freedman A; Garland JA; Jones BR; Race JW; Du Toit MS; Treharne JD; Wright DJ
    Trans Ophthalmol Soc U K (1962); 1966; 86():335-48. PubMed ID: 5335100
    [No Abstract]   [Full Text] [Related]  

  • 36. Latency in human infections with TRIC agents.
    Hanna L; Dawson CR; Briones O; Thygeson P; Jawetz E
    J Immunol; 1968 Jul; 101(1):43-50. PubMed ID: 4173937
    [No Abstract]   [Full Text] [Related]  

  • 37. The biologic properties of TRIC agents isolated from human conjunctiva in South Australia.
    Howarth WH; Hardy D; Crompton DO; Surman PG
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1041-4. PubMed ID: 4961060
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics and unknowns of TRIC agents (trachoma--inclusion conjunctivitis)].
    Nabli B
    Rev Int Trach Pathol Ocul Trop Subtrop; 1980; 57(4):71-5. PubMed ID: 7280402
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pathobiology of TRIC agents].
    Jawetz E
    Rev Int Trach; 1973; 50(3):27-38. PubMed ID: 4780351
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.
    Kuo C; Wang S; Wentworth BB; Grayston JT
    J Infect Dis; 1972 Jun; 125(6):665-8. PubMed ID: 4624816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.